Zhejiang Chengyi Pharmaceutical Co. Ltd.SSE: 603811

Report for Q3 2025

Oct 28, 2025 · Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 28, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-449

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix

Earlier from Zhejiang Chengyi Pharmaceutical

Announcement on Completion of the Government’s Compensatory Recovery of Land and Associated Assets of SubsidiariesOct 14, 2025
Announcement on Shareholding Reduction Plan for Person Acting in Concert of Controlling ShareholderSep 20, 2025
Announcement on Outline of the 2025 Semi-annual Performance BriefingSep 19, 2025
Announcement on Completion of Non-trading Transfer under the 2025 Employee Stock Ownership PlanSep 18, 2025
Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership PlanSep 17, 2025

Later from Zhejiang Chengyi Pharmaceutical

Indicative Announcement on Change in Equity of Controlling Shareholders and Persons Acting in Concert Reaching 1% ScaleNov 15, 2025
Announcement on Completing Shareholding Reduction Plan for Person Acting in Concert of Controlling Shareholder and the Results of Shareholding ReductionNov 27, 2025
Announcement on Progress in Providing GuaranteeDec 3, 2025
Announcement on the Acquisition of Drug Registration Certificate for Torasemide TabletsDec 10, 2025
Announcement on Selection of Products for Continuation Procurement Under National Procurement Scheme After Agreement ExpiryFeb 11

All Zhejiang Chengyi Pharmaceutical news releases

Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang Chengyi Pharmaceutical